Sanofi will produce up to 12 million doses of coronavirus vaccine per month for rival Johnson & Johnson, the second time the French drugmaker is renovating production facilities to speed up supply of the vaccine from a rival company, while your own candidate faces delays.
Sanofi’s announcement on Monday was quickly announced by French President Emmanuel Macron, who relayed the development on his Twitter account.
“Together we must accelerate vaccine production with industry associations,” Macron tweeted.
Sanofi said its vaccine manufacturing facility in Marcy l’Etoile, France, will formulate and fill vials of Johnson & Johnson’s candidate vaccine, developed by its Janssen companies. Sanofi said its French plant is expected to produce about 12 million doses per month of the single-dose vaccine.
Sanofi CEO Paul Hudson said the company remains committed to its two COVID-19 vaccine programs but is also “stepping forward to show solidarity.” Sanofi has previously announced that it will help package and package 125 million doses of vaccines for rival Pfizer / BioNTech.